Literature DB >> 25852815

Phototherapy-induced Purpuric Eruption in a Neonate.

Jennifer LaRusso1, Joshua Wilson1, Roger Ceilley1.   

Abstract

Phototherapy is commonly utilized in the treatment of neonatal jaundice. The authors observed a rare cutaneous complication of visible blue light phototherapy in a neonate with hyperbilirubinemia. A three-day-old neonate was evaluated for a purpuric rash after initiation of phototherapy for treatment of hyperbilirubinemia. Cutaneous examination revealed purpuric, nonblanching, well-demarcated lesions on the chest, abdomen, arms, and chin with sparing at shielded sites. The history, physical examination, and laboratory results support the diagnosis of purpuric phototherapy-induced eruption. The authors present a case report of this uncommon cutaneous eruption in a transfused neonate undergoing phototherapy for treatment of hemolytic disease of the newborn.

Entities:  

Year:  2015        PMID: 25852815      PMCID: PMC4382146     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  9 in total

Review 1.  Phototherapy for neonatal jaundice.

Authors:  M Jeffrey Maisels; Antony F McDonagh
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 2.  The side effects of phototherapy for neonatal jaundice: what do we know? What should we do?

Authors:  Tao Xiong; Yi Qu; Stephanie Cambier; Dezhi Mu
Journal:  Eur J Pediatr       Date:  2011-04-01       Impact factor: 3.183

3.  Part III: phototherapy-induced purpura in the setting of transient porphyrinemia in a neonate.

Authors:  Melanie J Tuerk; Thomas H Konia; Philina M Lamb
Journal:  J Drugs Dermatol       Date:  2011-03       Impact factor: 2.114

4.  Transient erythroporphyria of infancy.

Authors:  R I Crawford; E R Lawlor; L D Wadsworth; J S Prendiville
Journal:  J Am Acad Dermatol       Date:  1996-11       Impact factor: 11.527

5.  Purpuric phototherapy-induced eruption in transfused neonates: relation to transient porphyrinemia.

Authors:  A S Paller; L R Eramo; E E Farrell; D D Millard; P J Honig; B B Cunningham
Journal:  Pediatrics       Date:  1997-09       Impact factor: 7.124

Review 6.  Hyperbilirubinemia: current guidelines and emerging therapies.

Authors:  Hamilton P Schwartz; Beth E Haberman; Richard M Ruddy
Journal:  Pediatr Emerg Care       Date:  2011-09       Impact factor: 1.454

7.  Neonatal bullous eruption as a result of transient porphyrinemia in a premature infant with hemolytic disease of the newborn.

Authors:  E Mallon; F Wojnarowska; P Hope; G Elder
Journal:  J Am Acad Dermatol       Date:  1995-08       Impact factor: 11.527

8.  Bilirubin, copper-porphyrins, and the bronze-baby syndrome.

Authors:  Antony F McDonagh
Journal:  J Pediatr       Date:  2011-01       Impact factor: 4.406

9.  High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.

Authors:  J Rübo; K Albrecht; P Lasch; E Laufkötter; J Leititis; D Marsan; B Niemeyer; J Roesler; C Roll; B Roth
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

  9 in total
  3 in total

Review 1.  Two Faces of Heme Catabolic Pathway in Newborns: A Potential Role of Bilirubin and Carbon Monoxide in Neonatal Inflammatory Diseases.

Authors:  Wiktoria Osiak; Sławomir Wątroba; Lucyna Kapka-Skrzypczak; Jacek Kurzepa
Journal:  Oxid Med Cell Longev       Date:  2020-08-18       Impact factor: 6.543

2.  Comparison of efficacy, safety & satisfaction of intermittent versus continuous phototherapy in hyperbilirubinaemic newborns ≥35 week gestation: A randomized controlled trial.

Authors:  Sasi Bhushan Gottimukkala; Giridhar Sethuraman; Srinivasan Kitchanan; Surajit Pathak
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 2.375

3.  Role of Kangaroo Mother Care in the Management of Neonatal Hyperbilirubinemia in Both Term and Preterm Neonates: A Systematic Review.

Authors:  Bhawan Deep Garg; Anju Bansal; Nandkishor S Kabra
Journal:  J Perinat Educ       Date:  2020-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.